期刊文献+

肝移植术后脓毒症相关生物学标志物的研究进展

Research progress on biological markers related to sepsis after liver transplantation
下载PDF
导出
摘要 肝移植(liver transplantation,LT)手术是目前治疗各种终末期肝脏疾病的最好办法,而脓毒症依然是移植术后常见并发症之一,也是导致患者住院时间延长和死亡的主要原因。由于LT术中缺血-再灌注损伤,以及术后大剂量激素和免疫抑制剂的使用,使得术后早期准确识别脓毒症存在较大困难。近年来,关于预测LT术后新发脓毒症的生物学标志物研究日益增多,本文特针对这些研究成果进行回顾分析,以期为LT术后脓毒症的早期识别和防治提供参考。 At present,liver transplantation(LT) is the best way to treat a variety of end-stage liver diseases,while sepsis is still one of the common complications after transplantation,and it is also the main cause of prolonged hospitalization and death.Due to intraoperative ischemia-reperfusion injury,combined with the use of high-dose cortisol and immunosuppressants after operation,it is difficult to identify sepsis at the early stage after operation accurately and immediately.In recent years,research on the biomarkers for predicting new-onset sepsis after LT has been increasing.The article reviews and analyzes these research results in order to provide a guideline for the early identification and prevention of sepsis after LT.
作者 游潘 高榕悦 李文雄 黄立锋 You Pan;Gao Rong-yue;Li Wen-xiong;Huang Li-feng(Department of Surgical Intensive Care Unit,Beijing Chaoyang Hospital Affiliated to Capital Medical University,Beijing 100020,China)
出处 《中国急救医学》 CAS CSCD 2022年第8期728-732,共5页 Chinese Journal of Critical Care Medicine
基金 北京市临床重点专科(卓越)项目(2020年度) 北京市自然科学基金面上项目(7222065) 国家自然科学基金面上项目(81372042)。
关键词 肝移植(LT) 脓毒症 生物学标志物 Liver transplantation(LT) Sepsis Biomarkers
  • 相关文献

参考文献3

二级参考文献26

  • 1王晓东,李维勤,虞文魁,李宁,黎介寿.创伤患者单核细胞表面人白细胞抗原-DR表达变化及其临床意义[J].中华创伤杂志,2006,22(8):570-573. 被引量:15
  • 2Bilbao I,Armadans L,Lazaro JL,et al. Predictive factors for early mortality following liver transplantation. Clin Transplant, 2003,17:401-411.
  • 3Hoflich C,Docke WD,Meisel C,et al. Regulatory immunodeficiency and monoeyte deactivation assessment based on HLADR expression. Clin Appl Immunol Rev, 2002,2 : 337-344.
  • 4Volk liD, Reinke P, Krausch D, et al. Monocyte deactivation- rationale for a new therapeutic strategy in sepsis. Intensive Care Med, 1996,22 Suppl 4 : S474-481.
  • 5Sedlackova L, Prucha M, Dostdl M. Immunological monitoring of sepsis using flow eytometry quantitation of monocyte HLA-DR expression and granuloeyte CD64 expression. Epidemiol Mikrobiol Imunol, 2005,54 : 54-61.
  • 6Lekkou A, Karakantza M, Mouzaki A,et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol, 2004,11 : 161-167.
  • 7Mant TG, Borozdenkova S, Bradford DB, et al. Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers. Int Immunopharmacol, 2008,8:701-707.
  • 8Bone RC,Balk RA,Cerra FB,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, the ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992,101 : 1644-1655.
  • 9Merli M,Nicolini G, Angeloni S, et al. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition, 2002,18:978-986.
  • 10李太红,冯国旗.评《新编药物学》第16版[J].中国保健,2008,16(20):976-978. 被引量:1

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部